(Total Views: 1072)
Posted On: 10/29/2020 9:57:27 PM
Post# of 154059
UK Marketing Authorization Holder Information:
Its interesting in the UK clinical trial info,
https://www.clinicaltrialsregister.eu/ctr-sea...1996-33/GB
they already mention the company that will be doing the packaging/distribution of Leronlimab
On line D.2.1.1.2, it says: that the “Name of the Marketing Authorisation holder,” is:
“SHARP CLINICAL SERVICES (UK) LIMITED.”
Sounds like this may be further along than the company has publically released information.
Read between the lines.
Its interesting in the UK clinical trial info,
https://www.clinicaltrialsregister.eu/ctr-sea...1996-33/GB
they already mention the company that will be doing the packaging/distribution of Leronlimab
On line D.2.1.1.2, it says: that the “Name of the Marketing Authorisation holder,” is:
“SHARP CLINICAL SERVICES (UK) LIMITED.”
Sounds like this may be further along than the company has publically released information.
Read between the lines.
(9)
(0)
